Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. [electronic resource]
Producer: 19970807Description: 1115-24 p. digitalISSN:- 0090-3493
- Adult
- Aged
- Double-Blind Method
- Female
- Humans
- Interleukin 1 Receptor Antagonist Protein
- Male
- Middle Aged
- Receptors, Interleukin-1 -- antagonists & inhibitors
- Recombinant Proteins -- therapeutic use
- Sepsis -- drug therapy
- Shock, Septic -- drug therapy
- Sialoglycoproteins -- therapeutic use
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.